Companies: 10,795·Total market cap: $144.5T
Windtree Therapeutics, Inc.

Windtree Therapeutics, Inc.

WINTOTCHealthcare● Active
$0.01
$-0.00(-0.69%)
Market Cap$482036
P/E Ratio
52W High$1.86
52W Low$0.01
Overview

Windtree Therapeutics, Inc.(WINT)股价预测与分析师目标价

华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。

wint · 股价预测 · 5 位分析师(近3月)· FMP · 更新于 2026年6月9日

分析师评级与共识

基于过去 3 个月内 5 位华尔街分析师

SellBuy

Buy

5 位分析师

共识

评级分布

Strong Buy
0
Buy
3
Hold
2
Sell
0
Strong Sell
0
合计: 5 · 买入占比: 60.0%

12 个月目标价

High

$0.00

Consensus

$0.00

+0.0% upside

Low

$0.00

Median: $0 · Last Close: $0.01

Windtree Therapeutics, Inc.(WINT)的分析师共识为 Buy,基于过去 3 个月内 5 位华尔街分析师的评级。WINT 的 12 个月平均目标价为 $0.00,相对当前价 $0.01 代表 +0.0% 的潜在上行空间。

短期股价预测

算法生成 · 每日更新

DatePredicted PriceChange
2026-06-10$0.015.00%

1-day model range: $0.01–$0.01. Peak: $0.01 (-5.00%).

长期股价预测

⚠️ 在满 252 个交易日历史(IPO/上市时间较短)前不展示长期预测;短期标签页仍可能显示模型输出。

基于技术分析的股价预测

14 项技术面信号(SMA×6 + EMA×6 + RSI + MACD)· EEAT 方法论透明

Market Sentiment

BEARISH

Based on 14 technical indicators

0%36%64%
0Buy
5Neutral
9Sell
RSI (14)41.8Neutral
MACDBEARISH

Refreshes daily from EOD close

Moving Averages · WINT · Jun 9, 2026

Simple Moving Average (SMA)
MA 5$0.01SELL
MA 10$0.01SELL
MA 20$0.02SELL
MA 50$0.02SELL
MA 100$0.00NEUTRAL
MA 200$0.00NEUTRAL
Current $WINT · Price above MA = BUY signal
Exponential Moving Average (EMA)
EMA 5$0.01SELL
EMA 10$0.01SELL
EMA 20$0.02SELL
EMA 50$0.02SELL
EMA 100$0.00NEUTRAL
EMA 200$0.00NEUTRAL
Current $WINT · Price above MA = BUY signal
How we calculate: Technical sentiment is derived from 14 indicators — SMA(5,10,20,50,100,200), EMA(5,10,20,50,100,200), RSI(14), and MACD(12,26,9) — calculated from historical EOD price data. BUY = current price above MA; SELL = below. 14 TA signals + historical EOD price data · Updated daily. Independent of analyst consensus data. Not investment advice.

最新分析师评级与调整

Filter:
HC Wainwright & Co.2024-12-04
Maintains
NeutralNeutral
Oppenheimer2021-06-04
Maintains
OutperformOutperform
H.C. Wainwright2020-11-25
Maintains
BuyBuy
Ladenburg Thalmann2020-11-25
Maintains
BuyBuy
Ladenburg Thalmann2020-06-26
Maintains
BuyBuy
Stifel Nicolaus2017-06-30
Downgrade ↓
BuyHold
HC Wainwright & Co.2016-04-22
Maintains
BuyBuy
H.C. Wainwright2016-04-22
Maintains
BuyBuy

Wall Street analysts have recently issued updated ratings on Windtree Therapeutics, Inc. (WINT) stock. Of the recent 8 rating actions, 0 were upgrades and 1 were downgrades. 5 analysts currently cover WINT.

分析师推荐趋势

Buy ratings202
Hold ratings01↑ +1
Sell ratings00

WINT analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 2 to 0 per month.

财务预测:EPS 与营收一致预期

Revenue This Year

$2M

↓ 83.9% YoY

Revenue Next Year

$12M

↑ 510.0% YoY

EPS This Year

$-173.00

EPS Next Year

$-486.50

↑ 181.2% YoY

EPS ForecastReported vs Estimated

Reported EPSHistorical estimateAnalyst forecast (future)

Analysts forecast WINT EPS of $-173.00 for the current fiscal year, based on estimates from 1 analysts. The WINT revenue forecast is $2M for the current year. These are analyst consensus estimates via FMP / S&P Global.

关于预测与目标价

WINT 股价预测由两类独立数据源支撑:来自 5 位华尔街分析师(S&P Global / FMP)的共识评级,以及基于历史日终价计算的技术分析。WINT 的共识目标价为 $0.00(+0.0% 上行空间),分析师共识为 Buy。

WINT 的短期预测(明日)为 $0.01(-5.00%)。

Windtree Therapeutics, Inc. 在 OTC 上市,代码 WINT。WINT 在 2027 年的整体展望偏积极,在覆盖分析师中约 60% 对应 Buy 共识。

常见问题答案综合分析师目标价、一致预期及页面展示的模型结果。

常见问题

WINT 预测 · 8 个问题

根据 5 位华尔街分析师,WINT 的 12 个月平均目标价为 $0.00,最高 $0.00、最低 $0.00。若有图表,中位目标价可在上方查看。相对当前价 $0.01,隐含约 +0.0% 的上行空间。

WINT 目标价WINT 分析师目标价WINT 12个月目标价目标价 WINT

· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)

⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.